person

Belmira B.

Country
Portugal
Department
Serviço de Oftalmologia, ULS-LOD

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 22 partner sites.

Specializations

Ophthalmology – Retinal Vascular and Choroidal Disorders

The investigator focuses on diseases affecting the retinal and choroidal circulation, including polypoidal choroidal vasculopathy and related macular conditions.

  • Intravitreal therapeutic development
  • Choroidal neovascularization management
  • Best corrected visual acuity optimization

Advanced imaging and functional assessments guide therapeutic decisions.

Oncology – Lung and Breast Cancer Therapeutics

Key interests include targeted and endocrine strategies for non‑small cell lung cancer and breast cancer, with attention to molecular subtypes such as HER2‑negative disease.

  • Tyrosine kinase inhibitor combinations
  • Hormone‑receptor driven therapies
  • Biomarker‑guided treatment selection

Clinical programs aim to improve progression‑free survival across tumor types.

Cardiovascular and Renal Medicine

Research addresses high‑risk vascular conditions such as atherosclerotic cardiovascular disease, hypertension, and complications of end‑stage kidney disease.

  • Inflammation‑modulating agents
  • Renal‑cardiac outcome studies
  • Risk stratification in chronic kidney patients

Therapeutic efforts target reduction of cardiovascular events in vulnerable populations.

Pulmonary Fibrosis and Interstitial Lung Disease

The investigator is involved in trials for fibrotic lung disorders, notably idiopathic pulmonary fibrosis and progressive pulmonary fibrosis.

  • Antifibrotic drug evaluation
  • Functional respiratory endpoints
  • Long‑term safety monitoring

Focus is on preserving lung capacity and slowing disease progression.

Neurology – Stroke and Neurodegenerative Disorders

Clinical interests encompass acute and chronic nervous system conditions, including acute ischemic stroke, multiple system atrophy, and primary progressive multiple sclerosis.

  • Neuroprotective intervention trials
  • Functional outcome measures
  • Biomarker‑driven patient selection

Efforts aim to enhance recovery and modify disease trajectories.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.